• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂蛋白(a)测量在儿童和青少年心血管风险分层中的重要性如何?

Is lipoprotein(a) measurement important for cardiovascular risk stratification in children and adolescents?

机构信息

Istituto Auxologico Italiano, IRCCS, Via L. Ariosto 13, Milano, 20145, Italy.

Biostatistics and Clinical Epidemiology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.

出版信息

Ital J Pediatr. 2024 Sep 4;50(1):161. doi: 10.1186/s13052-024-01732-8.

DOI:10.1186/s13052-024-01732-8
PMID:39227973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11373248/
Abstract

BACKGROUND

Elevated lipoprotein (Lp(a)) levels are associated with increased risk of atherosclerotic processes and cardiovascular events in adults. The amount of Lp(a) is mainly genetically determined. Therefore, it is important to identify individuals with elevated Lp(a) as early as possible, particularly if other cardiovascular risk factors are present. The purpose of the study was to investigate whether, in a population of children and adolescents already followed for the presence of one or more cardiovascular risk factors (elevated blood pressure (BP), and/or excess body weight, and/or dyslipidemia), the measurement of Lp(a) can be useful for better stratifying their risk profile.

METHODS

In a sample of 195 children and adolescents, height, body weight, waist circumference and systolic (SBP) and diastolic (DBP) BP were measured. Body Mass Index (BMI) and SBP and DBP z-scores were calculated. Plasma Lp(a), total cholesterol, high-density lipoprotein (HDL), triglycerides, glucose, insulin, uric acid and creatinine were assessed. Low-density lipoprotein (LDL) cholesterol was calculated with the Friedewald formula. High Lp(a) was defined as ≥ 75 nmol/L and high LDL cholesterol as ≥ 3.37 mmol/L.

RESULTS

Our sample of children and adolescents (54.4% males, mean age 11.5 years) had median LDL cholesterol and Lp(a) values equal to 2.54 (interquartile range, IQR: 2.07-3.06) mmol/L and 22 (IQR: 7.8-68.6) nmol/L respectively. 13.8% of children had LDL cholesterol ≥ 3.37 mmol/L and 22.6 Lp(a) values ≥ 75 nmol/L. Lp(a) values were higher in children of normal weight than in those with excess weight (p = 0.007), but the difference disappeared if normal weight children referred for dyslipidemia only were excluded from the analysis (p = 0.210). 69.4% of children had normal Lp(a) and LDL cholesterol values and only 6.2% showed both elevated Lp(a) and LDL cholesterol levels. However, 16.6% of the sample, despite having normal LDL cholesterol, had elevated Lp(a) values. Multivariable analyses showed a significant association of LDL cholesterol both with Lp(a) values, and with the presence of elevated Lp(a) levels. For each mmol/L increase in LDL cholesterol the risk of having an elevated Lp(a) value increased by 73%. There was an inverse correlation between BMI z-score and Lp(a). Neither BP z-scores, nor other biochemical parameters were associated with Lp(a).

CONCLUSIONS

In our population more than one out of five children had elevated Lp(a) values, and in about 17% of children elevated Lp(a) values were present in the absence of increased LDL cholesterol. Our results suggest that Lp(a) measurement can be useful to better define the cardiovascular risk profile in children and adolescents already followed for the presence of other cardiovascular risk factors such as elevated BP, excess body weight and high LDL cholesterol.

摘要

背景

脂蛋白(Lp(a))水平升高与成人动脉粥样硬化过程和心血管事件风险增加有关。Lp(a)的水平主要由遗传决定。因此,尽早识别出 Lp(a)升高的个体非常重要,特别是如果存在其他心血管危险因素。本研究旨在探讨在已经存在一个或多个心血管危险因素(血压升高和/或超重,和/或血脂异常)的儿童和青少年人群中,测量 Lp(a)是否可以更好地分层其风险状况。

方法

在 195 名儿童和青少年的样本中,测量了身高、体重、腰围以及收缩压(SBP)和舒张压(DBP)。计算了体重指数(BMI)和 SBP 和 DBP 的 z 分数。评估了血浆 Lp(a)、总胆固醇、高密度脂蛋白(HDL)、甘油三酯、葡萄糖、胰岛素、尿酸和肌酐。使用 Friedewald 公式计算低密度脂蛋白(LDL)胆固醇。高 Lp(a)定义为≥75nmol/L,高 LDL 胆固醇定义为≥3.37mmol/L。

结果

我们的儿童和青少年样本(54.4%为男性,平均年龄为 11.5 岁)的 LDL 胆固醇和 Lp(a)中位数分别为 2.54(四分位距,IQR:2.07-3.06)mmol/L 和 22(IQR:7.8-68.6)nmol/L。13.8%的儿童 LDL 胆固醇≥3.37mmol/L,22.6%的儿童 Lp(a)值≥75nmol/L。与超重儿童相比,体重正常的儿童 Lp(a)值更高(p=0.007),但如果将仅因血脂异常而就诊的体重正常儿童从分析中排除,差异就会消失(p=0.210)。69.4%的儿童 LDL 胆固醇和 Lp(a)值正常,只有 6.2%的儿童同时出现 LDL 胆固醇和 Lp(a)值升高。然而,样本中仍有 16.6%的儿童尽管 LDL 胆固醇正常,但 Lp(a)值升高。多变量分析显示 LDL 胆固醇与 Lp(a)值以及升高的 Lp(a)水平均有显著相关性。LDL 胆固醇每增加 1mmol/L,Lp(a)值升高的风险就会增加 73%。BMI z 分数与 Lp(a)呈负相关。BP z 分数和其他生化参数均与 Lp(a)无关。

结论

在我们的人群中,超过五分之一的儿童 Lp(a)值升高,约 17%的儿童在 LDL 胆固醇升高的情况下出现 Lp(a)值升高。我们的结果表明,在已经存在其他心血管危险因素(如血压升高、超重和高 LDL 胆固醇)的儿童和青少年中,测量 Lp(a)可以更好地定义心血管风险状况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8387/11373248/32b95c1fec35/13052_2024_1732_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8387/11373248/32b95c1fec35/13052_2024_1732_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8387/11373248/32b95c1fec35/13052_2024_1732_Fig1_HTML.jpg

相似文献

1
Is lipoprotein(a) measurement important for cardiovascular risk stratification in children and adolescents?脂蛋白(a)测量在儿童和青少年心血管风险分层中的重要性如何?
Ital J Pediatr. 2024 Sep 4;50(1):161. doi: 10.1186/s13052-024-01732-8.
2
Lipoprotein profiles, not anthropometric measures, correlate with serum lipoprotein(a) values in children: the Taipei children heart study.脂蛋白谱而非人体测量指标与儿童血清脂蛋白(a)值相关:台北儿童心脏研究
Eur J Epidemiol. 2000 Jan;16(1):5-12. doi: 10.1023/a:1007692419117.
3
Lp(a)-cholesterol is associated with HDL-cholesterol in overweight and obese African American children and is not an independent risk factor for CVD.脂蛋白(a)-胆固醇与超重和肥胖的非裔美国儿童的高密度脂蛋白胆固醇相关,而不是 CVD 的独立危险因素。
Cardiovasc Diabetol. 2012 Jan 27;11:10. doi: 10.1186/1475-2840-11-10.
4
Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting.在一级预防环境中,脂蛋白(a)升高与心血管疾病风险的相关性在低低密度脂蛋白胆固醇水平时减弱。
Eur Heart J. 2018 Jul 14;39(27):2589-2596. doi: 10.1093/eurheartj/ehy334.
5
Neck circumference: a useful screening tool of cardiovascular risk in children.颈围:儿童心血管风险的一种有用筛查工具。
Pediatr Obes. 2012 Jun;7(3):187-95. doi: 10.1111/j.2047-6310.2012.00052.x. Epub 2012 Apr 13.
6
Association between general and central adiposity in childhood, and change in these, with cardiovascular risk factors in adolescence: prospective cohort study.儿童时期总体和中心性肥胖的相关性,以及这些肥胖在青春期的变化与心血管危险因素的关系:前瞻性队列研究。
BMJ. 2010 Nov 25;341:c6224. doi: 10.1136/bmj.c6224.
7
Lipoprotein(a) as a potent risk indicator for early cardiovascular disease.脂蛋白(a)作为早期心血管疾病的有力风险指标。
Acta Paediatr. 2002;91(12):1313-7. doi: 10.1080/08035250216114.
8
Correlation between lipoprotein(a) and other risk factors for cardiovascular disease and diabetes in Cherokee Indians: the Cherokee Diabetes Study.切罗基印第安人中脂蛋白(a)与心血管疾病和糖尿病其他风险因素之间的相关性:切罗基糖尿病研究
Ann Epidemiol. 2005 May;15(5):390-7. doi: 10.1016/j.annepidem.2005.01.003.
9
Impact of Lipoprotein(a) Levels on Cardiovascular Risk Estimation.脂蛋白(a)水平对心血管风险评估的影响。
High Blood Press Cardiovasc Prev. 2024 Jul;31(4):381-388. doi: 10.1007/s40292-024-00649-x. Epub 2024 May 13.
10
Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in adolescents: the healthy young cross-sectional study.肥胖和心血管代谢标志物对青少年脂蛋白相关磷脂酶 A2(Lp-PLA2)活性的影响:健康年轻的横断面研究。
Lipids Health Dis. 2013 Feb 15;12:19. doi: 10.1186/1476-511X-12-19.

引用本文的文献

1
Age-Dependent Clinical Relevance of Lipoprotein(a): A Comprehensive Review from Childhood to Adulthood.脂蛋白(a)的年龄依赖性临床相关性:从儿童期到成年期的全面综述
J Clin Med. 2025 Aug 26;14(17):6018. doi: 10.3390/jcm14176018.

本文引用的文献

1
Lipoprotein(a) as a Risk Factor for Cardiovascular Diseases: Pathophysiology and Treatment Perspectives.脂蛋白(a)作为心血管疾病的危险因素:病理生理学和治疗观点。
Int J Environ Res Public Health. 2023 Sep 6;20(18):6721. doi: 10.3390/ijerph20186721.
2
Significance of lipids, lipoproteins, and apolipoproteins during the first 14-16 months of life.生命最初 14-16 个月期间脂类、脂蛋白和载脂蛋白的意义。
Eur Heart J. 2023 Nov 7;44(42):4408-4418. doi: 10.1093/eurheartj/ehad547.
3
Consensus document on Lipoprotein(a) from the Italian Society for the Study of Atherosclerosis (SISA).
脂蛋白(a)共识文件来自意大利动脉粥样硬化研究学会(SISA)。
Nutr Metab Cardiovasc Dis. 2023 Oct;33(10):1866-1877. doi: 10.1016/j.numecd.2023.07.019. Epub 2023 Jul 19.
4
Evidence and Uncertainties on Lipoprotein(a) as a Marker of Cardiovascular Health Risk in Children and Adolescents.脂蛋白(a)作为儿童和青少年心血管健康风险标志物的证据与不确定性
Biomedicines. 2023 Jun 8;11(6):1661. doi: 10.3390/biomedicines11061661.
5
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia.载脂蛋白(a)基因型影响家族性高胆固醇血症的临床诊断。
J Am Heart Assoc. 2023 May 16;12(10):e029223. doi: 10.1161/JAHA.122.029223. Epub 2023 May 15.
6
Consensus and guidelines on lipoprotein(a) - seeing the forest through the trees.脂蛋白(a)共识和指南——透过现象看本质。
Curr Opin Lipidol. 2022 Dec 1;33(6):342-352. doi: 10.1097/MOL.0000000000000855. Epub 2022 Oct 14.
7
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.脂蛋白(a)与动脉粥样硬化性心血管疾病及主动脉瓣狭窄:欧洲动脉粥样硬化学会共识声明。
Eur Heart J. 2022 Oct 14;43(39):3925-3946. doi: 10.1093/eurheartj/ehac361.
8
Recent advances in demystifying the metabolism of lipoprotein(a).脂蛋白(a)代谢之谜的最新研究进展。
Atherosclerosis. 2022 May;349:82-91. doi: 10.1016/j.atherosclerosis.2022.04.002.
9
Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene.载脂蛋白(a)除了kringle IV 重复多态性:LPA 基因遗传变异的复杂性。
Atherosclerosis. 2022 May;349:17-35. doi: 10.1016/j.atherosclerosis.2022.04.003.
10
Lipoprotein(a) and its Significance in Cardiovascular Disease: A Review.脂蛋白(a)及其在心血管疾病中的意义:综述。
JAMA Cardiol. 2022 Jul 1;7(7):760-769. doi: 10.1001/jamacardio.2022.0987.